MENU

BYSI BeyondSpring Forecast, Technical & Fundamental Analysis

a manufacturer of cancer therapies

Industry Biotechnology
BYSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
BYSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BYSI is expected to report earnings to rise 29.31% to -75 cents per share on July 10

BeyondSpring BYSI Stock Earnings Reports
Q1'23
Est.
$-0.75
Q4'22
Missed
by $0.30
Q3'22
Missed
by $0.21
Q2'22
Missed
by $0.13
Q1'22
Est.
$-0.23
The last earnings report on April 18 showed earnings per share of -57 cents, missing the estimate of -28 cents. With 31.54K shares outstanding, the current market capitalization sits at 88.66M.
A.I. Advisor
published General Information

General Information

a manufacturer of cancer therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
28 Liberty Street
Phone
+1 646 305-6387
Employees
67
Web
https://www.beyondspringpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

BYSI and Stocks

Correlation & Price change

A.I.dvisor tells us that BYSI and APGE have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BYSI and APGE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BYSI
1D Price
Change %
BYSI100%
-5.39%
APGE - BYSI
26%
Poorly correlated
-5.41%
XRTX - BYSI
25%
Poorly correlated
+5.24%
NCNA - BYSI
23%
Poorly correlated
-7.10%
SMMT - BYSI
23%
Poorly correlated
-2.93%
NRXP - BYSI
22%
Poorly correlated
-12.03%
More

Groups containing BYSI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BYSI
1D Price
Change %
BYSI100%
-5.39%
pharmaceuticals
theme (167 stocks)
8%
Poorly correlated
+0.82%
cancer
theme (87 stocks)
1%
Poorly correlated
+0.89%